Clinical Trials Directory

Intensive Rhythm Monitoring to Decrease Ischemic Stroke and Systemic Embolism - the Find-AF 2 Study

Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

"NORPLASMA Covid-19 Convalescent Plasma Treatment Monitoring Study"

"HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for Intermediate Risk HPV-16-associated Head and Neck Squamous Cell Carcinoma"

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Biomarkers and Choroidal Neovascularization

SELUTION SLR™ 014 In-stent Restenosis

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Effect of Dietary Supplements on the Oral Microbiome

Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

HCT With PTCy in Higher-risk MDS

A Comparison of Visual Functions and Side-effects After DSAEK or DMEK for Fuchs' Endothelial Dystrophy

The Brain Injury Neurorehabilitation Project

Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery

Cell Free DNA Quantification in Patients With Endometriosis Followed Witd Medical Assistance to Procreation

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Prospective Surveillance of Lung Development During Childhood, Adolescence and Adulthood in Healthy and Patients With Cystic Fibrosis

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

Non-Operative Management and Early Response Assessment in Rectal Cancer

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

Utrecht COhort for Lung Cancer Outcome Reporting and Trial Inclusion (U-COLOR)

Northeast COVID-19 and Pregnancy Study Group

Arthroscopic Treatment Combined With PRP Injection for Refractory Elbow Epicondylitis

Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test

Family History Study on Cancer Risk

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

The Corona and COVID-19 Study in Telemark and Agder

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab

Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors

Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

Bilateral Treatment of Medication Refractory Essential Tremor

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study